Effects of chronic bromocriptine (CB-154) treatment on the plasma glucose and insulin secretion response to neurocytoglucopenia in rats

Journal of Endocrinology

Volumn 162, Issue 2, 1999, Pages 237-242

  Ribeiro De Oliveira Jr , A ^a   Guerra, R M ^a   Foscolo R B ^a   Marubayashi, U ^a   Reis, A M ^a   Coimbra, C C ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GLUCOSE; INSULIN;

ARTICLE; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; DOPAMINERGIC SYSTEM; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RAT; SYMPATHETIC TONE;

ANIMALS; BLOOD GLUCOSE; BROMOCRIPTINE; DEOXYGLUCOSE; GLUCOSE; INSULIN; RATS; RATS, WISTAR;

EID: 0032786518     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1620237     Document Type: Article

References (41)

1. Artalejo AR, Garcia AG, Montiel C, Hervas PP & Gonzales MC 1985 Dopaminergic receptor modulates catecholamine release from the cat adrenal gland. Journal of Physiology 362 359-368.
2. Brezenoff HE, Xiao YF & Vargas H 1988 A comparison of the central and peripheral antimuscarinic effects of atropine and methylatropine injected systematically and into the cerebral ventricles. Life Sciences 42 905-911.
3. Brown J 1962 Effects of 2-deoxyglucose on carbohydrate metabolism: review of the literature and studies in the rat. Metabolism 11 1098-1112.
4. Campfield LA, Smith FJ & Larue-Achagiotis C 1986 Temporal evolution of altered islet neurotransmitter sensitivity after VMH lesion. American Journal of Physiology 251 R63-R69.
5. Carlsson S, Skarphedinsson JO, DeLe M, Hoffman P & Thoren P 1992 Differential responses in post-and pre-ganglionic adrenal sympathetic nerve activity and renal sympathetic nerve activity after injection of 2-deoxy-D-glucose and insulin in rats. Acta Physiologica Scandinavia 145 169-175.
6. Cincotta AH & Meier AH 1996 Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects. Diabetes Care 19 667-670.
7. Cincotta AH, Shiller BC & Meier AH 1991 Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus, auratus. Metabolism 40 639-644.
8. Coimbra CC & Migliorini RH 1983 Evidence for a longitudinal pathway in rat hypothalamus that controls FFA mobilization. American Journal of Physiology 245 E332-E337.
9. Coimbra CC & Migliorini RH 1986 Insulin-sensitive glucoreceptors in rat preoptic area that regulate FFA mobilization. American Journal of Physiology 251 E703-E706.
10. Coimbra CC, Gross JL & Migliorini RH 1979 Intraventricular 2-deoxyglucose, glucose, insulin, and free fatty acid mobilization. American Journal of Physiology 236 E317-E322.
11. Dejong A, Strubbe JH & Steffens AB 1977 Hypothalamic influence on insulin and glucagon release in the rat. American Journal of Physiology 233 E380-E388.
12. Frohman LA, Muller EE & Cocchi D 1973 Central nervous system mediated inhibition of insulin secretion due to 2-deoxy-D-glucose. Hormone and Metabolic Research 5 21-26.
13. Gonzales MC, Artalejo AR, Montiel C Hervas PP & Garcia AG 1986 Characterization of a dopaminergic receptor that modulates adrenomedullary catecholamine release. Journal of Neurochemistry 47 382-388.
14. Harms PG & Ojeda SR 1974 A rapid and simple procedure for chronic cannulation of the rat jugular vein. Journal of Applied Physiology 36 391-392.
15. Havel PJ & Taborsky GJ 1989 The contribution of the autonomie nervous system to changes of glucagon and insulin secretion during hypoglycemic stress. Endocrine Reviews 10 332-350.
16. Ionescu E, Coimbra CC, Walker CD & Jeanrenaud B 1989 Paraventricular nucleus modulation of glycemia and insulinemia in freely moving lean rats. American Journal of Physiology 257 R1370-R1376.
17. McCaleb ML & Myers RD 1982 2-Deoxy-D-glucose and insulin modify release of norepinephrine from rat hypothalamus. American Journal of Physiology 242 R596-R601.
18. Matsunaga H, Iguchi A, Yatomi A, Uemura K, Miura H, Gotoh M, Mano T & Sakamoto N 1989 The relative importance of nervous system and hormones to the 2-deoxy-D-glucose-induced hyperglycemia in fed rats. Endocrinology 124 1259-1264.
19. N'Guyen JM, Magnan C, Laury MC, Thibault C, Leveteau J, Gilbert M, Penicaud L & Ktorza A 1994 Involvement of the autonomic nervous system in the in vivo memory to glucose of pancreatic β cell in rats. Journal of Clinical Investigation 94 1456-1462.
20. Okajima T, Motomatsu T, Kato K & Ibayashi H 1980 Naloxone inhibits prolactin and growth hormone release induced by intracellular glucopenia in the rat. Life Sciences 27 755-760.
21. Peinado JM & Myers RD 1987 Norepinephrine release from PVN and lateral hypothalamus during perfusion with 2-DG or insulin in sated and fasted rat. Pharmacology Biochemistry and Behavior 27 715-721.
22. Quik M & Sourkes TL 1977 Central dopaminergic and serotonergic system in the regulation of adrenal tyrosine hydroxylase. Journal of Neurochemistry 28 137-147.
23. Reis FM, Santos MAR, Reis AM & Coimbra CC 1994 Effects of hyperprolactinemia on plasma glucose and prolactin in rats exposed to ether stress. Physiology and Behaviour 56 495-499.
24. Reis FM, Ribeiro-de-Oliveira A Jr, Guerra RM, Reis AM & Coimbra CC 1996a Blood glucose and prolactin in hyperprolactinemic rats exposed to restraint and surgical stress. Life Sciences 58 155-161.
25. Reis FM, Santos MAR, Reis AM & Coimbra CC 1996b Alterations in plasma prolactin and glucose levels induced by surgical stress in hyperprolactinemic female rats. Brazilian Journal of Medical and Biological Research 29 811-815.
26. Reis FM, Reis AM & Coimbra CC 1997 Effects of hyperprolactinaemia on glucose tolerance and insulin release in male and female rats. Journal of Endocrinology 153 423-428.
27. Reis FM, Ribeiro-de-Oliveira A Jr, Machado LJC, Guerra RM, Reis AM & Coimbra CC 1998 Plasma prolactin and glucose alterations induced by surgical stress: a single or dual response? Experimental Physiology 83 1-10.
28. Saller CF & Kreamer LD 1991 Glucose concentrations in brain and blood: regulation by dopamine receptor subtypes. Brain Research 546 235-240.
29. Schmidt MJ, Root MA & Hall JL 1983 Dopamine agonist-induced hyperglycemia in rats: structure-activity relationships and mechanisms of action. European Journal of Pharmacology 90 169-177.
30. Shimazu T 1987 Neuronal regulation of hepatic glucose metabolism in mammals. Diabetes/Metabolism Reviews 3 185-206.
31. Smith FJ & Campfield LA 1986 Pancreatic adaptation in VMH obesity: in vivo compensatory response to altered neural input. American Journal of Physiology 251 R70-R76.
32. Smith GP, Gibbs J, Strohmayer AJ, Root AW & Stokes PE 1973 Effect of 2-deoxy-D-glucose on insulin response to glucose in intact and adrenomedullectomized monkeys. Endocrinology 92 750-754.
33. Smythe GA, Grunstein HS, Bradshaw JE, Nicholson MV & Compton PJ 1984 Relationship between brain noradrenergic activity and blood glucose. Nature 308 65-67.
34. Smythe GA, Pascoe WS & Storlien LH 1989 Hypothalamic noradrenergic and sympathoadrenal control of glycemia after stress. American Journal of Physiology 256 E231-E235.
35. Sorenson RL & Brelje TC 1997 Adaptation of islet of Langerhans to pregnancy: B-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Hormone and Metabolic Research 29 301-307.
36. Steffens AB, Strubbe JH, Balkan B & Scheunnk AJW 1991 Neuroendocrine factors regulating blood glucose, plasma FFA and insulin in the development of obesity. Brain Research Bulletin 27 505-510.
37. Storlien LH, Grunstein HS & Smythe GA 1985 Guanethidine blocks the 2-deoxy-D-glucose-induced hypothalamic noradrenergic drive to hyperglycemia. Brain Research 335 144-147.
38. Takahashi A, Ishimaru H, Ikarashi Y, Kishi E & Maruyama Y 1994 Aspects of hypothalamic neuronal system in VMH lesion-induced obese rats. Journal of the Autonomic Nervous System 48 213-219.
39. Woolf PD, Lee LA, Leebaw W, Thompson D, Lilavivathana U, Brodows R & Campbell R 1977 Intracellular glucopenia causes prolactin release in man. Journal of Clinical Endocrinology and Metabolism 45 377-383.
40. Yamamoto H, Nagai K & Nakagawa H 1988 Time-dependent involvement of autonomic nervous system in hyperglycemia due to 2-deoxy-D-glucose. American Journal of Physiology 255 E928-E933.
41. Zawalich W, Zawalich K & Rasmussen H 1989 Cholinergic agonists prime the β-cell to glucose stimulation. Endocrinology 125 2400-2406.